The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Targeting lactate metabolism for cancer therapeutics
Open accessAbstract
Lactate, once considered a waste product of glycolysis, has emerged as a critical regulator of cancer development, maintenance, and metastasis.Indeed, tumor lactate levels correlate with increased metastasis, tumor recurrence, and poor outcome.Lactate mediates cancer cell intrinsic effects on metabolism and has additional non-tumor cell autonomous effects that drive tumorigenesis.Tumor cells can metabolize lactate as an energy source and shuttle lactate to neighboring cancer cells, adjacent stroma, and vascular endothelial cells, which induces metabolic reprogramming.Lactate also plays roles in promoting tumor inflammation and in functioning as a signaling molecule that stimulates tumor angiogenesis.Here we review the mechanisms of lactate production and transport and highlight emerging evidence indicating that targeting lactate metabolism is a promising approach for cancer therapeutics. Lactate homeostasis in cancer cellsCancer cells are programmed to rely on aerobic glycolysis to support their proliferation and anabolic growth, an observation known as the Warburg effect (1, 2).Aerobic glycolysis rapidly generates ATP and diverts carbon from glucose into precursors for the synthesis of nucleotides, proteins, and lipids.As a consequence of this switch, glucose is preferentially catabolized to lactate, rather than fully metabolized to carbon dioxide via mitochondrial oxidative phosphorylation (OXPHOS).Glutamine catabolism by cancer cells also supports anabolic growth, sustains TCA cycle intermediates, and regulates redox homeostasis (3-5).These activities augment lactate production, albeit to a lesser extent than the lactate derived from glucose catabolism.Specifically, glutaminase (GLS) directs the conversion of glutamine to glutamate, which is then converted to α-ketoglutarate (αKG) by glutamate dehydrogenase that enters the TCA cycle.Malate that is then generated from αKG can exit the TCA cycle and be converted to pyruvate by malic enzyme (ME), which contributes to redox homeostasis via NADPH production.An alternate use of glutamine in pancreatic ductal carcinomas involves the transamination of glutamate and oxaloacetate (OAA) to αKG and aspartate (5).Aspartate exits the mitochondria and is transaminated back to OAA and glutamate; OAA is then converted to malate and subsequently to pyruvate.Finally, pyruvate is converted to lactate by the enzyme lactate dehydrogenase A (LDHA, Figure 1).Oncogenic lesions in cancer drive the switch to aerobic glycolysis and lactate production by inducing the expression and activation of several glycolytic enzymes (Figure 1).First, aberrant PI3K/AKT signaling induces the expression and cell surface expression of high-affinity glucose transporters (i.e., GLUT1 and GLUT4) and the activation of hexokinase 2 (HK2) and 6-phosphofructokinase 1 (PFK1) (6-8).Second, the transcriptional oncoproteins MYC and HIF-1α induce the expression of several glycolytic enzymes, including HK2, glucose-6-phosphate isomerase (GPI), PFK1, aldolase (ALDO), fructose bisphosphate (FBP), triose phosphate isomerase (TPI), GAPDH, phosphoglycerate kinase (PGK1), enolase 1 (ENO1), pyruvate kinase, muscle (PKM), and LDHA (9-12).In addition, MYC augments glutamine catabolism by inducing the LDH and its roles in tumorigenesis LDH mediates bidirectional conversion of pyruvate and lactate and is an emerging anticancer target (Figure 2).LDH is a tetramer composed of two different subunits, LDHA and LDHB, which Conflict of interest: The authors have declared that no conflict of interest exists.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
Ward, P. S., & Thompson, C. B. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.014 · Cited by 3,233
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Gao, P., Tchernyshyov, I., Chang, T.-C., Lee, Y.-S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T., et al. (2009) · Nature · doi:10.1038/nature07823 · Cited by 2,124
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X.-Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810199105 · Cited by 2,001
Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., et al. (2013) · Nature · doi:10.1038/nature12040 · Cited by 1,990
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice
Sonveaux, P., Végran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N., De Saedeleer, C. J., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,624
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Vander Jagt, D. L., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,516
The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma
Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10238 · Cited by 1,391
Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer
DeBerardinis, R. J., & Cheng, T. (2010) · Oncogene · doi:10.1038/onc.2009.358 · Cited by 1,365
Kohn, A. D., Summers, S. A., Birnbaum, M. J., & Roth, R. A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.49.31372 · Cited by 1,284
HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer
David, C. J., Chen, M., Assanah, M., Canoll, P., & Manley, J. L. (2010) · Nature · doi:10.1038/nature08697 · Cited by 1,179
c-Myc transactivation of LDH-A : Implications for tumor metabolism and growth
Shim, H., Dolde, C., Lewis, B. C., Wu, C.-S., Dang, G., Jungmann, R. A., Dalla-Favera, R., & Dang, C. V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6658 · Cited by 1,092
Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R. B., & Hay, N. (2001) · Genes & Development · doi:10.1101/gad.889901 · Cited by 961
The relevance of tumour pH to the treatment of malignant disease
Wike-Hooley, J. L., Haveman, J., & Reinhold, H. S. (1984) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(84)80077-8 · Cited by 903
Ullah, M. S., Davies, A. J., & Halestrap, A. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511397200 · Cited by 890
Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc
Osthus, R. C., Shim, H., Kim, S., Li, Q., Reddy, R., Mukherjee, M., Xu, Y., Wonsey, D., Lee, L. A., & Dang, C. V. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000023200 · Cited by 879
Lu, H., Forbes, R. A., & Verma, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 837
Coller, H. A., Grandori, C., Tamayo, P., Colbert, T., Lander, E. S., Eisenman, R. N., & Golub, T. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3260 · Cited by 823
Végran, F., Boidot, R., Michiels, C., Sonveaux, P., & Feron, O. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2828 · Cited by 816
Activity-dependent regulation of energy metabolism by astrocytes: an update
Pellerin, L., Bouzier‐Sore, A., Aubert, A., Serres, S., Merle, M., Costalat, R., & Magistretti, P. J. (2007) · Glia · doi:10.1002/glia.20528 · Cited by 805
The monocarboxylate transporter family—Role and regulation
Halestrap, A. P., & Wilson, M. C. (2012) · IUBMB Life · doi:10.1002/iub.572 · Cited by 741
Tumor-derived lactic acid modulates dendritic cell activation and antigen expression
Gottfried, E., Kunz-Schughart, L. A., Ebner, S., Mueller-Klieser, W., Hoves, S., Andreesen, R., Mackensen, A., & Kreutz, M. (2006) · Blood · doi:10.1182/blood-2005-05-1795 · Cited by 729
The monocarboxylate transporter family—Structure and functional characterization
Halestrap, A. P. (2012) · IUBMB Life · doi:10.1002/iub.573 · Cited by 710
Kirk, P., Wilson, M. C., Heddle, C., Brown, M. H., Barclay, A. N., & Halestrap, A. P. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.3896 · Cited by 700
Kim, J.-W., Gao, P., Liu, Y.-C., Semenza, G. L., & Dang, C. V. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00440-07 · Cited by 658
Fiaschi, T., Marini, A., Giannoni, E., Taddei, M. L., Gandellini, P., De Donatis, A., Lanciotti, M., Serni, S., Cirri, P., & Chiarugi, P. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1949 · Cited by 578
DIMMER, K.-S., Friedrich, B., Lang, F. J. W., Deitmer, J. W., & Bröer, S. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3500219 · Cited by 577
Markert, C. L., Shaklee, J. B., & Whitt, G. S. (1975) · Science · doi:10.1126/science.1138367 · Cited by 562
Dawson, D. M., Goodfriend, T. L., Kaplan, N. O., & Kaplan, N. O. (1964) · Science · doi:10.1126/science.143.3609.929 · Cited by 548
Sonveaux, P., Copetti, T., De Saedeleer, C. J., Végran, F., Verrax, J., Kennedy, K. M., Moon, E. J., Dhup, S., Danhier, P., Frérart, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033418 · Cited by 536
Martinez-Outschoorn, U. E., Balliet, R. M., Rivadeneira, D., Chiavarina, B., Pavlides, S., Wang, C., Whitaker-Menezes, D., Daumer, K., Lin, Z., Witkiewicz, A., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.16.12553 · Cited by 460
Deprez, J., Vertommen, D., Alessi, D. R., Hue, L., & Rider, M. H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17269 · Cited by 449
Hashimoto, T., Hussien, R., Oommen, S., Gohil, K., & Brooks, G. A. (2007) · The FASEB Journal · doi:10.1096/fj.07-8174com · Cited by 435
Le Floch, R., Chiche, J., Marchiq, I., Naiken, T., Ilc, K., Murray, C. M., Critchlow, S. E., Roux, D., Simon, M.-P., & Pouysségur, J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106123108 · Cited by 429
Whitaker-Menezes, D., Martinez-Outschoorn, U. E., Lin, Z., Ertel, A., Flomenberg, N., Witkiewicz, A. K., Birbe, R., Howell, A., Pavlides, S., Gandara, R., et al. (2011) · Cell Cycle · doi:10.4161/cc.10.11.15659 · Cited by 409
Lactic Acid and Acidification Inhibit TNF Secretion and Glycolysis of Human Monocytes
Dietl, K., Renner, K., Dettmer, K., Timischl, B., Eberhart, K., Dorn, C., Hellerbrand, C., Kastenberger, M., Kunz-Schughart, L. A., Oefner, P. J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902584 · Cited by 401
Reversible Inactivation of HIF-1 Prolyl Hydroxylases Allows Cell Metabolism to Control Basal HIF-1
Lu, H., Dalgard, C. L., Mohyeldin, A., McFate, T., Tait, A. S., & Verma, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508718200 · Cited by 400
for the ‘Tumour and Angiogenesis Research Group’, Koukourakis, M. I., Giatromanolaki, A., Sivridis, E., Bougioukas, G., Didilis, V, Gatter, K. C., & Harris, A. L. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601205 · Cited by 377
Kim, J.-W., Zeller, K. I., Wang, Y., Jegga, A. G., Aronow, B. J., O'Donnell, K. A., & Dang, C. V. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.5923-5936.2004 · Cited by 371
Minchenko, A., Leshchinsky, I., Opentanova, I., Sang, N., Srinivas, V., Armstead, V., & Caro, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110978200 · Cited by 370
Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activation
Mendler, A. N., Hu, B., Prinz, P. U., Kreutz, M., Gottfried, E., & Noessner, E. (2012) · International Journal of Cancer · doi:10.1002/ijc.26410 · Cited by 319
Wilson, M. C., Meredith, D., Fox, J. E. M., Manoharan, C., Davies, A. J., & Halestrap, A. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411950200 · Cited by 316
BRÖER, S., SCHNEIDER, H.-P., BRÖER, A., RAHMAN, B., HAMPRECHT, B., & DEITMER, J. W. (1998) · Biochemical Journal · doi:10.1042/bj3330167 · Cited by 310
The transcriptional program of a human B cell line in response to Myc
Schuhmacher, M. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.2.397 · Cited by 310
Gallagher, S. M., Castorino, J. J., Wang, D., & Philp, N. J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3184 · Cited by 288
Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway
Shime, H., Yabu, M., Akazawa, T., Kodama, K., Matsumoto, M., Seya, T., & Inoue, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7175 · Cited by 285
Lactate Activates HIF-1 in Oxidative but Not in Warburg-Phenotype Human Tumor Cells
De Saedeleer, C. J., Copetti, T., Porporato, P. E., Verrax, J., Feron, O., & Sonveaux, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046571 · Cited by 277
CD147 immunoglobulin superfamily receptor function and role in pathology
Iacono, K. T., Brown, A. L., Greene, M. I., & Saouaf, S. J. (2007) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2007.08.014 · Cited by 272
Ovens, M. J., Davies, A. J., Wilson, M. C., Murray, C. M., & Halestrap, A. P. (2010) · Biochemical Journal · doi:10.1042/bj20091515 · Cited by 260
Pullen, T. J., da Silva Xavier, G., Kelsey, G., & Rutter, G. A. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01433-10 · Cited by 258
Increased expression of monocarboxylate transporters 1, 2, and 4 in colorectal carcinomas
Pinheiro, C., Longatto-Filho, A., Scapulatempo, C., Ferreira, L., Martins, S., Pellerin, L., Rodrigues, M., Alves, V. A. F., Schmitt, F., & Baltazar, F. (2008) · Virchows Archiv · doi:10.1007/s00428-007-0558-5 · Cited by 255
Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets
Miranda-Gonçalves, V., Honavar, M., Pinheiro, C., Martinho, O., Pires, M. M., Pinheiro, C., Cordeiro, M., Bebiano, G., Costa, P., Palmeirim, I., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos298 · Cited by 252
Monocarboxylate transporter MCT1 is a target for immunosuppression
Murray, C. M., Hutchinson, R., Bantick, J. R., Belfield, G. P., Benjamin, A. D., Brazma, D., Bundick, R. V., Cook, I. D., Craggs, R. I., Edwards, S., et al. (2005) · Nature Chemical Biology · doi:10.1038/nchembio744 · Cited by 248
Minchenko, O., Opentanova, I., & Caro, J. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01179-7 · Cited by 236
Xie, H., Valera, V. A., Merino, M. J., Amato, A. M., Signoretti, S., Linehan, W. M., Sukhatme, V. P., & Seth, P. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-1049 · Cited by 233
Koukourakis, M. I., Giatromanolaki, A., Simopoulos, C., Polychronidis, A., & Sivridis, E. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-2343-7 · Cited by 227
Granchi, C., Roy, S., Giacomelli, C., Macchia, M., Tuccinardi, T., Martinelli, A., Lanza, M., Betti, L., Giannaccini, G., Lucacchini, A., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101007q · Cited by 227
Bonuccelli, G., Whitaker-Menezes, D., Castello-Cros, R., Pavlides, S., Pestell, R. G., Fatatis, A., Witkiewicz, A. K., Vander Heiden, M. G., Migneco, G., Chiavarina, B., et al. (2010) · Cell Cycle · doi:10.4161/cc.9.10.11601 · Cited by 220
Boidot, R., Végran, F., Meulle, A., Le Breton, A., Dessy, C., Sonveaux, P., Lizard-Nacol, S., & Feron, O. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2474 · Cited by 203
Lisanti, M. P., Martinez-Outschoorn, U. E., Chiavarina, B., Pavlides, S., Whitaker-Menezes, D., Tsirigos, A., Witkiewicz, A. K., Lin, Z., Balliet, R. M., Howell, A., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.6.13370 · Cited by 199
Galloflavin (CAS 568‐80‐9): A Novel Inhibitor of Lactate Dehydrogenase
Manerba, M., Vettraino, M., Fiume, L., Di Stefano, G., Sartini, A., Giacomini, E., Buonfiglio, R., Roberti, M., & Recanatini, M. (2012) · ChemMedChem · doi:10.1002/cmdc.201100471 · Cited by 198
Monocarboxylate transporter 1 is up‐regulated in basal‐like breast carcinoma
Pinheiro, C., Albergaria, A., Paredes, J., Sousa, B., Dufloth, R., Vieira, D., Schmitt, F., & Baltazar, F. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03560.x · Cited by 189
Colen, C. B., Shen, Y., Ghoddoussi, F., Yu, P., Francis, T. B., Koch, B. J., Monterey, M. D., Galloway, M. P., Sloan, A. E., & Mathupala, S. P. (2011) · Neoplasia · doi:10.1593/neo.11134 · Cited by 187
Liu, G., Kelly, W. K., Wilding, G., Leopold, L., Brill, K., & Somer, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2985 · Cited by 181
Izumi, H., Takahashi, M., Uramoto, H., Nakayama, Y., Oyama, T., Wang, K., Sasaguri, Y., Nishizawa, S., & Kohno, K. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.01908.x · Cited by 179
Pérez de Heredia, F., Wood, I. S., & Trayhurn, P. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0750-3 · Cited by 179
Pértega-Gomes, N., Vizcaíno, J. R., Miranda-Gonçalves, V., Pinheiro, C., Silva, J., Pereira, H., Monteiro, P., Henrique, R. M., Reis, R. M., Lopes, C., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-312 · Cited by 178
Fang, J., Quinones, Q. J., Holman, T. L., Morowitz, M. J., Wang, Q., Zhao, H., Sivo, F., Maris, J. M., & Wahl, M. L. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.026245 · Cited by 172
Rodriguez, S., Jafer, O., Goker, H., Summersgill, B. M., Zafarana, G., Gillis, A. J. M., van Gurp, R. J. H. L. M., Oosterhuis, J. W., Lu, Y.-J., Huddart, R., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206302 · Cited by 168
Sotgia, F., Whitaker-Menezes, D., Martinez-Outschoorn, U. E., Flomenberg, N., Birbe, R., Witkiewicz, A. K., Howell, A., Philp, N. J., Pestell, R. G., & Lisanti, M. P. (2012) · Cell Cycle · doi:10.4161/cc.19841 · Cited by 166
Baggstrom, M. Q., Qi, Y., Koczywas, M., Argiris, A., Johnson, E. A., Millward, M. J., Murphy, S. C., Erlichman, C., Rudin, C. M., & Govindan, R. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31822e2941 · Cited by 161
van Arensbergen, J., García-Hurtado, J., Moran, I., Maestro, M. A., Xu, X., Van de Casteele, M., Skoudy, A. L., Palassini, M., Heimberg, H., & Ferrer, J. (2010) · Genome Research · doi:10.1101/gr.101709.109 · Cited by 161
Schneiderhan, W., Scheler, M., Holzmann, K.-H., Marx, M., Gschwend, J. E., Bucholz, M., Gress, T. M., Seufferlein, T., Adler, G., & Oswald, F. (2009) · Gut · doi:10.1136/gut.2009.181412 · Cited by 161
Farabegoli, F., Vettraino, M., Manerba, M., Fiume, L., Roberti, M., & Di Stefano, G. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.08.012 · Cited by 158
Thangaraju, M., Carswell, K. N., Prasad, P. D., & Ganapathy, V. (2008) · Biochemical Journal · doi:10.1042/bj20081132 · Cited by 153
Lactate dehydrogenase M-subunit deficiency: a new type of hereditary exertional myopathy
Kanno, T., Sudo, K., Maekawa, M., Nishimura, Y., UKITA, M., & Fukutake, K. (1988) · Clinica Chimica Acta · doi:10.1016/0009-8981(88)90359-2 · Cited by 149
Lactate Dehydrogenase B Is Required for the Growth of KRAS-Dependent Lung Adenocarcinomas
McCleland, M. L., Adler, A. S., Deming, L., Cosino, E., Lee, L. B., Blackwood, E. M., Solon, M., Tao, J., Li, L., Shames, D. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2638 · Cited by 149
Mathupala, S. P., Parajuli, P., & Sloan, A. E. (2004) · Neurosurgery · doi:10.1227/01.neu.0000143034.62913.59 · Cited by 147
Yu, Y., Deck, J. A., Hunsaker, L. A., Deck, L. M., Royer, R. E., Goldberg, E., & Jagt, D. L. V. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00636-0 · Cited by 139
Structural and Biochemical Studies of TIGAR (TP53-induced Glycolysis and Apoptosis Regulator)
Li, H., & Jogl, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807821200 · Cited by 127
Lactate dehydrogenase-B is silenced by promoter hypermethylation in human prostate cancer
Leiblich, A., Cross, S. S., Catto, J. W. F., Phillips, J. T., Leung, H. Y., Hamdy, F. C., & Rehman, I. (2006) · Oncogene · doi:10.1038/sj.onc.1209262 · Cited by 125
Gerlinger, M., Santos, C. R., Spencer‐Dene, B., Martinez, P., Endesfelder, D., Burrell, R. A., Vetter, M. H. F., Jiang, M., Saunders, R. E., Kelly, G. P., et al. (2012) · The Journal of Pathology · doi:10.1002/path.4006 · Cited by 112
Blocking CD147 induces cell death in cancer cells through impairment of glycolytic energy metabolism
Baba, M., Inoue, M., Itoh, K., & Nishizawa, Y. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.122 · Cited by 110
Deck, L. M., Royer, R. E., Chamblee, B. B., Hernandez, V. M., Malone, R. R., Torres, J. E., Hunsaker, L. A., Piper, R. C., Makler, M. T., & Jagt, D. L. V. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980334n · Cited by 107
Pinheiro, C. M., Longatto‐Filho, A., Ferreira, L., Pereira, S. M. M., Etlinger, D., Moreira, M. A. R., Jubé, L. F., Queiroz, G. S., Schmitt, F. C., & Baltazar, F. (2008) · International Journal of Gynecological Pathology · doi:10.1097/pgp.0b013e31817b5b40 · Cited by 103
IL-23-dependent and -independent enhancement pathways of IL-17A production by lactic acid
Yabu, M., Shime, H., Hara, H., Saito, T., Matsumoto, M., Seya, T., Akazawa, T., & Inoue, N. (2010) · International Immunology · doi:10.1093/intimm/dxq455 · Cited by 98
Gossypol Prototype of Inhibitors Targeted to Dinucleotide Folds
Jagt, D. L. V., Deck, L. M., & Royer, R. E. (2000) · Current Medicinal Chemistry · doi:10.2174/0929867003375119 · Cited by 95
Koukourakis, M. I., Giatromanolaki, A. N., Winter, S. C., Leek, R., Sivridis, E., & Harris, A. L. (2009) · Oncology · doi:10.1159/000259260 · Cited by 93
Ovens, M. J., Manoharan, C., Wilson, M. C., Murray, C. M., & Halestrap, A. P. (2010) · Biochemical Journal · doi:10.1042/bj20100890 · Cited by 92
Phase I/II Study of AT-101 with Topotecan in Relapsed and Refractory Small Cell Lung Cancer
Heist, R. S., Fain, J., Chinnasami, B., Khan, W. A., Molina, J. R., Sequist, L. V. D., Temel, J. S., Fidias, P. M., Brainerd, V., Leopold, L. H., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181e8f4dc · Cited by 87
Nilsson, L. M., Plym Forshell, T. Z., Rimpi, S., Kreutzer, C., Pretsch, W., Bornkamm, G. W., & Nilsson, J. A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002573 · Cited by 85
Inhibitory effects of statins on human monocarboxylate transporter 4
Kobayashi, M., Otsuka, Y., Itagaki, S., Hirano, T., & Iseki, K. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.043 · Cited by 81
Colen, C. B., Seraji‐Bozorgzad, N., Marples, B., Galloway, M. P., Sloan, A. E., & Mathupala, S. P. (2006) · Neurosurgery · doi:10.1227/01.neu.0000249218.65332.bf · Cited by 76
Reduced Expression of GNA11 and Silencing of MCT1 in Human Breast Cancers
Asada, K., Miyamoto, K., Fukutomi, T., Tsuda, H., Yagi, Y., Wakazono, K., Oishi, S., Fukui, H., Sügimura, T., & Ushijima, T. (2003) · Oncology · doi:10.1159/000070297 · Cited by 73
de Oliveira, A. T. T., Pinheiro, C. M., Longatto‐Filho, A., Brito, M. J., Martinho, O., Matos, D., Carvalho, A. L., Vazquez, V. D. L., Silva, T. B., Scapulatempo‐Neto, C., et al. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9408-5 · Cited by 65
Molecular characterization of genetic mutation in human lactate dehydrogenase-A (M) deficiency
Maekawa, M., Sudo, K., Kanno, T., & Li, S. S. ‐. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)92374-9 · Cited by 58
Promoter Hypermethylation in Cancer Silences LDHB, Eliminating Lactate Dehydrogenase Isoenzymes 1-4
Maekawa, M., Taniguchi, T., Ishikawa, J., Sugimura, H., Sugano, K., & Kanno, T. (2003) · Clinical Chemistry · doi:10.1373/49.9.1518 · Cited by 54
Inhibition of tumor lactate oxidation: Consequences for the tumor microenvironment
Busk, M., Walenta, S., Mueller‐Klieser, W., Steiniche, T., Jakobsen, S., Horsman, M. R., & Overgaard, J. (2011) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2011.05.053 · Cited by 43
Lactate-Induced IL-8 Pathway in Endothelial Cells—Letter
Pinheiro, C. M., Longatto‐Filho, A., Nogueira, R. N., Schmitt, F. C., & Baltazar, F. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1540 · Cited by 11
Cited by
Next-generation characterization of the Cancer Cell Line Encyclopedia
Ghandi, M., Huang, F. W., Jané-Valbuena, J., Kryukov, G. V., Lo, C. C., McDonald, E. R., Barretina, J., Gelfand, E. T., Bielski, C. M., Li, H., et al. (2019) · Nature · doi:10.1038/s41586-019-1186-3 · Cited by 3,394
Kleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Cancer metabolism: a therapeutic perspective
Martinez-Outschoorn, U. E., Peiris-Pagés, M., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.60 · Cited by 1,505
The Science and Translation of Lactate Shuttle Theory
Brooks, G. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.03.008 · Cited by 1,486
Foxp3 Reprograms T Cell Metabolism to Function in Low-Glucose, High-Lactate Environments
Angelin, A., Gil-de-Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M. H., Wang, Z., Quinn, W. J., Kopinski, P. K., Wang, L., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.018 · Cited by 1,246
Metadata
- Authors
- Doherty, J. R., & Cleveland, J. L.
- Venue
- Journal of Clinical Investigation
- Published
- 2013-09-03
- Volume
- 123
- Issue
- 9
- Pages
- 3685-3692
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1964959571
- Cited by
- 1,166
- References
- 106
- FWCI
- 18.73
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.